Kite Pharma is soaring on positive trial results of its engineered T-cells for fighting cancer, but there are plenty of hurdles ahead for everyone working in the nascent field of immuno-oncology.

from Forbes – Tech http://ift.tt/2doOJcC
via IFTTT